Avalo Therapeutics, Inc. — SC 13G/A Filings
18 SC 13G/A filings on record
This page lists all SC 13G/A filings submitted to the SEC by Avalo Therapeutics, Inc. (AVTX), sorted by most recent first. Each row links to the full filing on EdgarLookup. Avalo Therapeutics, Inc. has filed 18 SC 13G/A documents with the SEC since 2015. To view all SEC filings by Avalo Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
10-Q/A
144
25-NSE
3
4
4/A
424B3
424B4
424B5
425
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DEFR14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
POS AM
PRE 14A
PRER14A
S-1
S-1/A
S-3
S-3/A
S-4
S-4/A
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G/A | — | 0001013594-24-000957 | Nov 14, 2024 | — |
| SC 13G/A | — | 0001493152-24-044038 | Nov 7, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-24-024255 | Feb 14, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-24-023903 | Feb 14, 2024 | — |
| SC 13G/A | — | 0001172661-24-001522 | Feb 14, 2024 | — |
| SC 13G/A | AVALO THERAPEUTICS, INC. | 0000902664-24-001630 | Feb 14, 2024 | — |
| SC 13G/A | — | 0001929354-23-000017 | Jun 29, 2023 | — |
| SC 13G/A | — | 0001929354-23-000004 | Apr 19, 2023 | — |
| SC 13G/A | SC 13G/A | 0001104659-23-021885 | Feb 14, 2023 | — |
| SC 13G/A | SCHEDULE 13G/A, AMENDMENT #2 | 0000899140-23-000400 | Feb 14, 2023 | — |
| SC 13G/A | — | 0001929354-23-000001 | Feb 14, 2023 | — |
| SC 13G/A | 13GA | 0001929354-22-000004 | Aug 8, 2022 | — |
| SC 13G/A | SCHEDULE 13G (AMENDMENT NO. 1) | 0000899140-22-000309 | Feb 14, 2022 | — |
| SC 13G/A | SC 13G/A | 0001104659-22-021628 | Feb 14, 2022 | — |
| SC 13G/A | — | 0001493152-20-002534 | Feb 14, 2020 | — |
| SC 13G/A | — | 0001493152-19-002111 | Feb 14, 2019 | — |
| SC 13G/A | AMENDMENT NO. 1 | 0001144204-17-009324 | Feb 15, 2017 | — |
| SC 13G/A | NEA 14 / CERECOR INC - SCHEDULE 13G (AMEND. 1) | 0001072613-17-000055 | Feb 6, 2017 | — |